Table 1. Patients characteristics, with comparison of the included and excluded populations.
| Included N = 7245 |
Excluded N = 2435 |
P | ||
|---|---|---|---|---|
| Sex (M/W) | 5300 (72%) / 1945 (28%) | 1672 (68.7%) / 763 (31.3%) | <0.0001 | |
| Route of acquisition | Men having sex with men | 3388 (46.8%) | 981 (40.3%) | <0.0001 |
| Men having sex with women | 3260 (45.0%) | 1132 (46.5%) | ||
| IVDUa | 90 (1.2%) | 46 (1.9%) | ||
| Other/unknown | 507 (7%) | 276 (11.3%) | ||
| Diagnosis during Acute HIV infection | 788 (10.8%) | 188 (7.7%) | <0.0001 | |
| Age at HIV diagnosis (years, median IQR) | 36 (28–46) | 34 (28–43) | <0.0001 | |
| Age at ART prescription (years, median IQR) | 40 (32–50) | 39 (32–48) | 0.002 | |
| CD4 cell count at HIV diagnosis (/μL, median IQR) | 362 (198–537) | 295 (121–475) | <0.0001 | |
| HIV viral load at HIV diagnosis (log.copies/mL, median IQR) | 4.74 (4.1–5.3) | 4.9 (4.2–5.5) | <0.0001 | |
| CD4 cell count at ART prescription (/μL, median IQR) | 352 (197–505) | 297 (124–470) | <0.0001 | |
| HIV viral load at ART prescription (log.copies/mL, median, IQR) | 4.7 (4.1–5.2) | 4.9 (4.3–5.5) | <0.0001 | |
a: Intravenous drug use.